Dominic Piscitelli - 24 Feb 2026 Form 4 Insider Report for Oric Pharmaceuticals, Inc. (ORIC)

Reporting relationship: Chief Financial Officer
Issuer ticker: ORIC
Reported as of: 24 Feb 2026
Net transaction value: -$475,966
SEC form: 4
Accepted by SEC: 26 Feb 2026, 16:47:24 UTC
Prior SEC filing: 06 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Christian Kuhlen, attorney-in-fact

Key filing fact

Dominic Piscitelli filed Form 4 for Oric Pharmaceuticals, Inc. (ORIC) on 26 Feb 2026.

Key facts

This page summarizes Dominic Piscitelli's Form 4 filing for Oric Pharmaceuticals, Inc. (ORIC).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 26 Feb 2026, 16:47.

Change

Previous filing in this sequence was filed on 06 Jan 2026.
Current net transaction value: -$475,966.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001695028 Primary reporting owner

Piscitelli Dominic

Relationship: Chief Financial Officer
Address: C/O ORIC PHARMACEUTICALS, INC., 240 E. GRAND AVE., 2ND FLOOR, SOUTH SAN FRANCISCO
Signature: /s/ Christian Kuhlen, attorney-in-fact
Signature date: 26 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ORIC transaction

Common Stock

Options Exercise

Transaction value: $226,720
Shares: +52,000
Change %: +76%
Price: $4.36
Shares after: 120,148
Date: 24 Feb 2026
Ownership: Direct

ORIC transaction

Common Stock

Sale

Transaction value: $702,686
Shares: -52,000
Change %: -43%
Price: $13.51
Shares after: 68,148
Date: 24 Feb 2026
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ORIC transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -52,000
Change %: -26%
Price: $0.000000
Shares after: 144,500
Date: 24 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 52,000
Exercise price: $4.36

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 24, 2025.

Footnote F2

Represents the weighted average share price of an aggregate total of 52,000 shares sold in the price range of $13.50 to $13.53 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.